The Association between Use of Renin-Angiotensin-Aldosterone System Inhibitors and the Risk and Mortality of Pancreatic Cancer: A Systematic Review and Meta-Analysis.

Rasoul Rahimi Seyed Mahmoud Reza Hashemi Rafsanjani Saeid Heidari-Soureshjani Catherine M T SherwinKaramali Kasiri

Published in: Current reviews in clinical and experimental pharmacology (2024)

In summary, while renin-angiotensin-aldosterone system inhibitors did not appear to impact PC risk, their use was associated with lower PC mortality based on this meta-analysis of the current evidence. More rigorous and well-designed studies are required to validate and support these findings.

Keyphrases

angiotensin converting enzyme
angiotensin ii
cardiovascular events
risk factors
type diabetes
coronary artery disease